<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[az Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/az.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to az]]></description>
	<s:counts start="0" returned="16" found="16" />
	<language>en-us</language>
	<item>
		<title><![CDATA[AZ's Seroquel Legal Bill Is $1.1B and Getting Bigger]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10005054/azs-seroquel-legal-bill-is-11b-and-getting-bigger/]]></link>
		<description><![CDATA[In AstraZeneca's Seroquel settlement with the U.S. Disrict Attorney in Pennsylvania, the headline number is $520 million. But the real cost to AZ is already much more than that: $1.1 billion. by Jim Edwards]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Fri, 30 Oct 2009 09:05:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AZ Loses $13M Zoladex Appeal in "Do the Math!" Case]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10004512/az-loses-13m-zoladex-appeal-in-do-the-math-case/]]></link>
		<description><![CDATA[AstraZeneca lost a federal appeals court ruling and must pay $13 million in damages for manipulating the price of prostate cancer drug Zoladex. The case involved an AZ campaign to persuade doctors to over-bill the government for Zoladex. It urged, "DO THE MATH!" in letters that explained how using Zoladex...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 29 Sep 2009 12:49:41 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/vertical+industries.html"><![CDATA[Vertical Industries]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
	</item>
	<item>
		<title><![CDATA[E-Mail: AstraZeneca Knew in 1997 that Seroquel Caused Weight Gain]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001228/e-mail-astrazeneca-knew-in-1997-that-seroquel-caused-weight-gain/]]></link>
		<description><![CDATA[AstraZeneca knew as far back as 1997 that Seroquel put patients at risk of weight gain, according to the company's own internal memos. The documents also appear to show that some AZ execs developed strategies to "neutralize" information that suggested Seroquel caused weight gain or diabetes, even after the FDA...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 03 Mar 2009 11:40:31 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/fda.html"><![CDATA[FDA]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/data.html"><![CDATA[Data]]></category>
		<category domain="http://resources.bnet.com/topic/diabetes.html"><![CDATA[Diabetes]]></category>
		<category domain="http://resources.bnet.com/topic/memo.html"><![CDATA[Memo]]></category>
		<category domain="http://resources.bnet.com/topic/e-mail.html"><![CDATA[E-mail]]></category>
		<category domain="http://resources.bnet.com/topic/seroquel.html"><![CDATA[Seroquel]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca's Sex-for-Studies Seroquel Scandal: Did Research Chief Bias the Science?]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001169/astrazenecas-sex-for-studies-seroquel-scandal-did-research-chief-bias-the-science/]]></link>
		<description><![CDATA[An AstraZeneca executive in charge of clinical research on Seroquel had sexual affairs with a researcher and a study writer, plaintiffs in a Florida lawsuit claim. BNET first wrote about the sex-for-secrets aspect of the Seroquel litigation on Feb. 17.    Now Furious Seasons blogger Philip Dawdy revealed...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 25 Feb 2009 11:54:08 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/researcher.html"><![CDATA[Researcher]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/macfadden.html"><![CDATA[Macfadden]]></category>
		<category domain="http://resources.bnet.com/topic/gender+and+diversity.html"><![CDATA[Gender And Diversity]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Novartis, Boehringer Start Using Twitter Accounts]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001062/novartis-boehringer-start-using-twitter-accounts/]]></link>
		<description><![CDATA[AstraZeneca, Novartis, Vertex Pharmaceuticals and Boehringer Ingelheim have started experimenting with Twitter with varying degrees of enthusiasm, reports Pharmaceutical Executive.    Drug companies have so far looked at social media with a mixture of fear and loathing. They believe perhaps wrongly that giving consumers more opportunities to talk...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 18 Feb 2009 10:02:53 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/drug+company.html"><![CDATA[Drug Company]]></category>
		<category domain="http://resources.bnet.com/topic/social+media.html"><![CDATA[Social Media]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/twitter.html"><![CDATA[Twitter]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/bi+site.html"><![CDATA[BI Site]]></category>
		<category domain="http://resources.bnet.com/topic/pricing.html"><![CDATA[Pricing]]></category>
		<category domain="http://resources.bnet.com/topic/business+intelligence.html"><![CDATA[Business Intelligence]]></category>
		<category domain="http://resources.bnet.com/topic/tools+%2526+techniques.html"><![CDATA[Tools & Techniques]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/data+management.html"><![CDATA[Data Management]]></category>
		<category domain="http://resources.bnet.com/topic/management.html"><![CDATA[Management]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="tickers">NVS</category>
	</item>
	<item>
		<title><![CDATA[Seroquel Trial: Allegations of Sex-for-Secrets; AZ Wants Papers Sealed]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/10001026/seroquel-trial-allegations-of-sex-for-secrets-az-wants-papers-sealed/]]></link>
		<description><![CDATA[AstraZeneca is to argue in a Florida court next month that documents turned up in a lawsuit over weight-gain side effects of Seroquel should remain secret and sealed. The company is arguing it would be better for public health for Seroquel patients not to read the papers, according to The...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Tue, 17 Feb 2009 11:19:38 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[Patient]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/seroquel.html"><![CDATA[Seroquel]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca: 15,000 Layoffs Through 2013; Company the "Worst" in Its Class]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000734/astrazeneca-15000-layoffs-through-2013-company/]]></link>
		<description><![CDATA[AstraZeneca announced plans for another 7,400 layoffs to take place before 2013. About 38 percent of those job cuts will come prior to 2010, the company said. The remainder will occur before 2013.    The company expects the "restructuring" to cost $2.9 billion, but to save $2.5 billion...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 29 Jan 2009 08:19:02 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/layoff.html"><![CDATA[Layoff]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/ing+group.html"><![CDATA[ING Group]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/research+%2526+development.html"><![CDATA[Research & Development]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/financial+accounting.html"><![CDATA[Financial Accounting]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[AstraZeneca's Role in Nobel Prizes Is Questioned]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000500/astrazenecas-role-in-nobel-prizes-is-questioned/]]></link>
		<description><![CDATA[UPDATE -- AstraZeneca failed to respond has now responded to BNET's request for comment, see below. The company alsoÂ provided a statement to Pharmalot. The company confirmed its sponsorship of Nobel organizations but denied it had influenced the judges: "Because the Nobel Committee of Karolinska Institute, and not the Nobel companies,...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Sun, 14 Dec 2008 16:03:34 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/details.html"><![CDATA[Details]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+governance.html"><![CDATA[Corporate Governance]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+law.html"><![CDATA[Corporate Law]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Infinity and AstraZeneca Split, Schering & Merck's PR Blunder, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000492/pharma-roundup-infinity-and-astrazeneca-split-schering-mercks-pr-blunder-and-more/]]></link>
		<description><![CDATA[A fond farewell between Infinity and AstraZeneca, a dubious PR honor for S-P and Merck over Vytorin, Lilly's ImClone-related costs mount, generics cost less. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 11 Dec 2008 17:02:22 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/merck+%2526+co.+inc..html"><![CDATA[Merck & Co. Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/medimmune+inc..html"><![CDATA[MedImmune Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/public+relations.html"><![CDATA[Public Relations]]></category>
		<category domain="http://resources.bnet.com/topic/business+structures.html"><![CDATA[Business Structures]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/corporate+communications.html"><![CDATA[Corporate Communications]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[Finance]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MRK</category>
		<category domain="tickers">AZN,MRK</category>
	</item>
	<item>
		<title><![CDATA[Abraxis Split Closes Door on a Rocky Patch for AstraZeneca]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000433/abraxis-split-closes-door-on-a-rocky-patch-for-astrazeneca/]]></link>
		<description><![CDATA[The split between AstraZeneca and Abraxis over their copromotion of cancer drug Abraxane was expected among some Abraxis reps since August of this year. Now it's official. The end of the agreement comes as the patent on Casodex expires in April 2009 and the company this week saw mixed results...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 26 Nov 2008 03:00:04 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/abraxis.html"><![CDATA[Abraxis]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[How AstraZeneca's U.S. Sales Reps Avoided the Current Round of Layoffs]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000414/how-astrazenecas-us-sales-reps-avoided-the-current-round-of-layoffs/]]></link>
		<description><![CDATA[AstraZeneca staff in the U.S. dodged a bullet this morning as the company announced 1,400 layoffs -- but none of them in America. The job losses will come instead in the U.K., Spain, Belgium and Sweden. AZ's explanation of the move was a masterpiece in cynical management-speak and news-burying. Its...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 20 Nov 2008 07:44:52 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/sweden.html"><![CDATA[Sweden]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/layoff.html"><![CDATA[Layoff]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force.html"><![CDATA[Sales Force]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://resources.bnet.com/topic/sweden.html"><![CDATA[Sweden]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/layoff.html"><![CDATA[Layoff]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force.html"><![CDATA[Sales Force]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/sales+force+management.html"><![CDATA[Sales Force Management]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/supply+chain+management+%2528scm%2529.html"><![CDATA[Supply Chain Management (SCM)]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/enterprise+software.html"><![CDATA[Enterprise Software]]></category>
		<category domain="http://resources.bnet.com/topic/software.html"><![CDATA[Software]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Pharma Roundup: Lawsuit for Roche, Teva Troubles for AstraZeneca, and More]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000410/pharma-roundup-lawsuit-for-roche-teva-troubles-for-astrazeneca-and-more/]]></link>
		<description><![CDATA[Roche must pay in lawsuit, Teva aiming for AstraZeneca's customers, AstraZeneca's new U.S. president, and Novartis in Cambridge. by John Maas]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 19 Nov 2008 18:28:06 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/lawsuit.html"><![CDATA[Lawsuit]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/lawsuit.html"><![CDATA[Lawsuit]]></category>
		<category domain="http://resources.bnet.com/topic/roche+holding+ag.html"><![CDATA[Roche Holding AG]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/john+maas.html"><![CDATA[John Maas]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[Teva Sues AstraZeneca Over Crestor: $2.8 Billion on the Line]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000275/teva-sues-astrazeneca-over-crestor-28-billion-on-the-line/]]></link>
		<description><![CDATA[Teva, the generic maker, is suing AstraZeneca, the holder of the original Crestor patent, claiming that AZ is somehow infringing on rights Teva acquired to the drug back in March 2007.    The Crestor patent isn't supposed to expire until 2016 -- well beyond the industry's looming patent...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Thu, 09 Oct 2008 08:54:14 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/astrazeneca+plc..html"><![CDATA[AstraZeneca Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/patent.html"><![CDATA[Patent]]></category>
		<category domain="http://resources.bnet.com/topic/teva.html"><![CDATA[Teva]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AZN</category>
		<category domain="tickers">AZN</category>
	</item>
	<item>
		<title><![CDATA[The 10 Weirdest Drug Stories of the Month]]></title>
		<link><![CDATA[http://industry.bnet.com/pharma/1000251/the-10-weirdest-drug-stories-of-the-month/]]></link>
		<description><![CDATA[Another page has been torn off the calendar, and that means it's time to open up Big Pharma's vault of peculiarities and do a roundup of strange-but-true tales from the world of drugs that surfaced on my radar last month.    I give you the 10 weirdest drug...]]></description>
		<s:doctype><![CDATA[Blog posts]]></s:doctype>
		<pubDate>Wed, 01 Oct 2008 07:50:19 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/movie.html"><![CDATA[Movie]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[Pharmaceutical Company]]></category>
		<category domain="http://resources.bnet.com/topic/swedes.html"><![CDATA[Swedes]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/indevus.html"><![CDATA[Indevus]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/workforce+management.html"><![CDATA[Workforce Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/human+resources.html"><![CDATA[Human Resources]]></category>
		<category domain="http://resources.bnet.com/topic/jim+edwards.html"><![CDATA[Jim Edwards]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">PFE</category>
	</item>
	<item>
		<title><![CDATA[Fitch Affirms Banner Health System At 'AA-'; Upcoming Debt Considered]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2002_August_22/ai_90640929]]></link>
		<description><![CDATA[Business Editors  NEW YORK--BUSINESS WIRE--Aug. 22, 2002  Fitch Ratings affirms the outstanding underlying rating of 'AA-' on approximately $520 million in outstanding debt issued on behalf of Banner Health System BHS formerly known as Discovery Health System. The outstanding issues affected are listed below. Fitch affirms the rating...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 22 Aug 2002 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/banner+health+system.html"><![CDATA[Banner Health System]]></category>
		<category domain="http://resources.bnet.com/topic/fitch+ratings.html"><![CDATA[Fitch Ratings]]></category>
		<category domain="http://resources.bnet.com/topic/phoenix+technologies.html"><![CDATA[Phoenix Technologies]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PTEC</category>
		<category domain="tickers">PTEC</category>
	</item>
	<item>
		<title><![CDATA[Reclamation, Ranching, and Reservation: Environmental, Cultural, and Governmental Rivalries in Transitional Arizona]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6474/is_3_40/ai_n28719350]]></link>
		<description><![CDATA[In the spring of 1996, Tonto National Forest burned spectacularly. The Lone Fire swept over 61,000 acres, much of which was within the Four Peaks Wilderness Area. During the week of the fire, the issue of appropriate land use captured the media's attention, as well as the attention of government...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 22 Sep 1998 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/a..html"><![CDATA[A.]]></category>
		<category domain="http://resources.bnet.com/topic/american.html"><![CDATA[American]]></category>
		<category domain="http://resources.bnet.com/topic/az.html"><![CDATA[AZ]]></category>
		<category domain="http://resources.bnet.com/topic/black.html"><![CDATA[Black]]></category>
		<category domain="http://resources.bnet.com/topic/e..html"><![CDATA[E.]]></category>
		<category domain="http://resources.bnet.com/topic/early.html"><![CDATA[Early]]></category>
		<category domain="http://resources.bnet.com/topic/history.html"><![CDATA[History]]></category>
		<category domain="http://resources.bnet.com/topic/holsinger.html"><![CDATA[Holsinger]]></category>
		<category domain="http://resources.bnet.com/topic/j..html"><![CDATA[J.]]></category>
		<category domain="http://resources.bnet.com/topic/john.html"><![CDATA[John]]></category>
		<category domain="http://resources.bnet.com/topic/phoenix+technologies.html"><![CDATA[Phoenix Technologies]]></category>
		<category domain="http://resources.bnet.com/topic/press.html"><![CDATA[Press]]></category>
		<category domain="http://resources.bnet.com/topic/s..html"><![CDATA[S.]]></category>
		<category domain="http://resources.bnet.com/topic/salt+river+project.html"><![CDATA[Salt River Project]]></category>
		<category domain="http://resources.bnet.com/topic/tempe.html"><![CDATA[Tempe]]></category>
		<category domain="http://resources.bnet.com/topic/west.html"><![CDATA[West]]></category>
		<category domain="http://resources.bnet.com/topic/western.html"><![CDATA[Western]]></category>
		<category domain="http://resources.bnet.com/topic/white.html"><![CDATA[White]]></category>
		<category domain="http://resources.bnet.com/topic/william.html"><![CDATA[William]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PTEC</category>
		<category domain="tickers">PTEC</category>
	</item>
</channel>
</rss>
